Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

University of Pennsylvania · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
cysticfibrosisdiabetesglucagonlikepeptide
cystic fibrosis, pancreatic insufficiency, abnormal glucose tolerance, diabetes, cystic fibrosis related diabetes, glucose intolerance, insulin secretion, glucagon-like peptide-1 (glp-1), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 803713
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.